|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/352 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61K 31/164 | (2013.01) | ||
| A61K 31/57 | (2006.01) | ||
| A61K 31/473 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 31/565 | (2013.01) | ||
| A61K 31/164 | (2006.01) | ||
| A61K 31/573 | (2013.01) | ||
| A61K 31/57 | (2013.01) | ||
| A61K 31/473 | (2006.01) | ||
| A61K 31/565 | (2006.01) | ||
| A61K 31/568 | (2013.01) | ||
| A61K 31/568 | (2006.01) | ||
| A61K 31/352 | (2013.01) | ||
| A61K 31/573 | (2006.01) | ||
| A61K 9/0014 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 21/02 | (2006.01) | ||
| A61P 1/10 | (2018.01) | ||
| A61P 25/16 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 13/02 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 21/02 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/02 | (2018.01) | ||
| A61P 25/08 | (2018.01) | ||
| A61P 25/16 | (2018.01) | ||
| A61P 25/18 | (2018.01) | ||
| A61P 25/20 | (2018.01) | ||
| A61P 25/22 | (2018.01) | ||
| A61P 25/24 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/16 | (2018.01) |
| (11) | Patento numeris | 3509585 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17849385.4 |
| Europos patento paraiškos padavimo data | 2017-09-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-07-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-11-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/050055 |
| Data | 2017-09-05 |
| (87) | Numeris | WO 2018/048789 |
| Data | 2018-03-15 |
| (30) | Numeris | Data | Šalis |
| 201662384458 P | 2016-09-07 | US |
| (72) |
CHANG, Wei-wei , US
SAWYER, Kenneth I. , US
|
| (73) |
Glia, LLC ,
134 Saint Botolph Street, Boston, Massachusetts 02115-4819,
US
|
| (54) | TREATMENT OF SYMPTOMS RELATED TO NEURODEGENERATIVE DISORDERS THROUGH PHARMACOLOGICAL DERMAL ACTIVATION OF CRANIAL NERVES |
| TREATMENT OF SYMPTOMS RELATED TO NEURODEGENERATIVE DISORDERS THROUGH PHARMACOLOGICAL DERMAL ACTIVATION OF CRANIAL NERVES |